APA (7th ed.) Citation

FM, F., D, P., AT, C., MS, S., VM, M., GD, J., . . . NJ, M. (2013). HDAC inhibitor confers radiosensitivity to prostate stem-like cells. British journal of cancer, 109(12), 3023. https://doi.org/10.1038/bjc.2013.691

Chicago Style (17th ed.) Citation

FM, Frame, Pellacani D, Collins AT, Simms MS, Mann VM, Jones GD, Meuth M, Bristow RG, and Maitland NJ. "HDAC Inhibitor Confers Radiosensitivity to Prostate Stem-like Cells." British Journal of Cancer 109, no. 12 (2013): 3023. https://doi.org/10.1038/bjc.2013.691.

MLA (9th ed.) Citation

FM, Frame, et al. "HDAC Inhibitor Confers Radiosensitivity to Prostate Stem-like Cells." British Journal of Cancer, vol. 109, no. 12, 2013, p. 3023, https://doi.org/10.1038/bjc.2013.691.

Warning: These citations may not always be 100% accurate.